OmniAb Inc
NASDAQ:OABI 9:45:38 AM EDT
| Market Cap (Intraday) | 209.95M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.68 |
| 50-Day MA | $1.59 |
| 200-Day MA | $3.06 |
OmniAb Inc Stock, NASDAQ:OABI
5980 Horton Street, Suite 600, Emeryville, California 94608
United States of America
Phone: +1.510.250.7800
Number of Employees: 114
Description
OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.